Literature DB >> 465282

N-Methyl-benzylamine, a metabolite of pargyline in man.

R Pirisino, G B Ciottoli, F Buffoni, B Anselmi, C Curradi.   

Abstract

1. N-methyl-benzylamine was identified in human urine and plasma after the administration of pargyline in man. This metabolite was identified by thin layer chromatography mobility, gas chromatographic retention time and mass spectrum relative to authentic N-methyl-benzylamine. 2. [14C]-N-methyl-benzylamine, together with a small amount of [14C]-benzylamine, was formed in vitro from [14C]-pargyline when this was incubated with human and rat liver microsomes. 3. The urinary excretion rates of pargyline and its metabolite have also been described.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 465282      PMCID: PMC1429678          DOI: 10.1111/j.1365-2125.1979.tb04648.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  3 in total

1.  The colorimetric estimation of formaldehyde by means of the Hantzsch reaction.

Authors:  T NASH
Journal:  Biochem J       Date:  1953-10       Impact factor: 3.857

2.  Identification and distribution of benzylamine in tissue extracts isolated from rats pretreated with pargyline.

Authors:  D A Durden; S T Philips; A A Boulton
Journal:  Biochem Pharmacol       Date:  1976-04-01       Impact factor: 5.858

3.  Routine detection and identification in urine of stimulants and other drugs, some of which may be used to modify performance in sport.

Authors:  A H Beckett; G T Tucker; A C Moffat
Journal:  J Pharm Pharmacol       Date:  1967-05       Impact factor: 3.765

  3 in total
  2 in total

1.  Pharmacokinetic and neurochemical studies on N-propargyl-2-phenylethylamine, a prodrug of 2-phenylethylamine.

Authors:  T S Rao; G B Baker; R T Coutts
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

Review 2.  Metabolism of monoamine oxidase inhibitors.

Authors:  G B Baker; L J Urichuk; K F McKenna; S H Kennedy
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.